Research & Educational Use Only. This protocol guide is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any research protocol.
Dual GLP-1/Glucagon Receptor Agonist
Weekly Protocol Guide
Survodutide Protocol Guide
Survodutide is a dual GLP-1 and glucagon receptor agonist studied for obesity and metabolic dysfunction-associated steatohepatitis (MASH). The dual mechanism targets appetite suppression via GLP-1 while glucagon receptor activation increases energy expenditure and hepatic lipid oxidation.
Protocol Overview
- Compound
- Survodutide (Research Peptide for Obesity and MASH)
- Category
- Dual GLP-1/Glucagon Receptor Agonist
- Vial Size
- 10mg (10,000mcg)
- Reconstitution
- 2mL bacteriostatic water (5mg/mL)
- Route
- Subcutaneous injection
- Frequency
- Once weekly
Reconstitution Instructions
Using 2mL of bacteriostatic water results in a concentration of 5mg/mL. Start low and titrate gradually. Always use sterile techniques.
Materials Needed
- 10mg Survodutide 10mg vial (lyophilized powder)
- 2mL bacteriostatic water (sterile, preserved with 0.9% benzyl alcohol)
- Sterile syringe and needle (18-22 gauge for drawing)
- Alcohol swabs
- Clean workspace
Step-by-Step Process
- Preparation: Allow the Survodutide 10mg vial and bacteriostatic water to reach room temperature. Wipe the rubber stoppers of both vials with an alcohol swab.
- Draw the Water: Using a sterile syringe, draw up exactly 2mL of bacteriostatic water. Expel any air bubbles.
- Inject into Vial: Insert the needle through the rubber stopper at a slight angle, aiming toward the glass wall. Slowly inject the water down the side of the vial to avoid foaming.
- Mix Gently: Remove the needle. Gently swirl or roll the vial between your hands. Do not shake vigorously.
- Check for Clarity: The solution should be clear once fully reconstituted. Do not use if cloudy.
Weekly Dosing Schedule
| Day | Units | Dose | Timing |
|---|---|---|---|
| Monday | 5 | 0.25mg | Morning |
Weekly Total: 5 units (0.25mg) • Vial Duration: ~40 weeks at starting dose
Quick Dosing Reference
| Units (Ticks) | Dose (mcg) | Dose (mg) |
|---|---|---|
| 2.5 | 125 | 0.125mg |
| 5 | 250 | 0.25mg |
| 10 | 500 | 0.5mg |
| 20 | 1000 | 1.0mg |
| 40 | 2000 | 2.0mg |
| 60 | 3000 | 3.0mg |
| 96 | 4800 | 4.8mg |
Administration Guidelines
- Administer subcutaneously once weekly on the same day each week
- Start at 0.25mg weekly and titrate up every 4 weeks
- Rotate injection sites between abdomen, thigh, and upper arm
- Monitor for GI side effects during titration
- Store reconstituted peptide refrigerated at 36-46F (2-8C)
- Use reconstituted solution within 30 days
- Never freeze reconstituted peptides
- Document administration times and observations
Storage Requirements
| State | Storage Conditions |
|---|---|
| Lyophilized (powder) | Room temperature or refrigerated, protect from light |
| Reconstituted | Refrigerated 36-46F (2-8C), use within 30 days |